Document is current
Any future updates will be listed below
-
Authors
Haney, Margaret
Cooper, Ziva D.
VanLaanen, Hannah
Hindocha, Chandni
Triemstra, Jennifer L. https://orcid.org/0000-0001-7075-7269
-
Funding
Funding for this research was provided by:
Jazz Pharmaceuticals, Inc.
- License Information
-
More Information
Article History
Accepted: 7 October 2025
First Online: 10 December 2025
Declarations
:
: MH has been a consultant for Anebulo Pharmaceuticals, is a stockholder of and on the scientific advisory board for PleoPharma and has received cannabis capsules from Tilray for research on neuropathic pain. ZDC reports receiving study drug and study supplies from Canopy Growth Corporation, True Terpenes, and Storz & Bickel. HV is an employee of SB Pharma Solutions, LLC. CH was employed by Jazz Pharmaceuticals, Inc., at the time the study was conducted. JLT is an employee of Jazz Pharmaceuticals, Inc, and holds stock and/or stock options in Jazz Pharmaceuticals, plc.
: Not applicable.
: Not applicable.
: Not applicable
: All relevant data are provided within the manuscript and supporting files.
: Not applicable
: HV: study concept and design, and statistical analysis. CH: study concept and design. JLT: study concept and design, obtained funding, study supervision, and administrative, technical or material support. MH, ZDC, HV, CH, and JLT were involved with the acquisition, analysis, or interpretation of data, and the drafting and critical review of the manuscript for important intellectual content. All authors have read and approved the final submitted manuscript and agree to be accountable for the work.
